The dosage, timing and duration of tolvaptan administration in Patients Hospitalized for Acute Decompensated Heart Failure
Phase 4
- Conditions
- Heart Failure
- Registration Number
- JPRN-UMIN000014441
- Lead Sponsor
- Ichinomiya Nishi Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
Contraindication of usage of tolvaptan
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method